Meeting
2023 ASCO Annual Meeting
The influence of sex on the impact of age and frailty on acute care use among older adults receiving immune checkpoint inhibitor (ICI) treatment: A population-based study.
Authors
Elizabeth Faour
Princess Margaret Cancer Centre, Toronto, ON, Canada
Elizabeth Faour , Rinku Sutradhar , Yosuf Kaliwal , Yue Niu , Ning Liu , Melanie Lynn Powis , Geoffrey Liu , Jeffrey M. Peppercorn , Monika K. Krzyzanowska , Shabbir M.H. Alibhai , Lawson Eng
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Geriatric Models of Care
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 12053)
DOI
10.1200/JCO.2023.41.16_suppl.12053
Abstract #
12053
Poster Bd #
421
Abstract Disclosures
Funded by Conquer Cancer
Similar Posters
Poster
2024 ASCO Annual Meeting
Early combination with mycophenolate mofetil for immune-related hepatitis in patients with solid tumors treated with immune checkpoint inhibitors.
First Author: Yukiko Shimoda Igawa
Poster
2023 ASCO Annual Meeting
Safety of checkpoint inhibitors in older patients with genitourinary cancers.
First Author: Brian Hemendra Ramnaraign
Poster
2022 ASCO Quality Care Symposium
The Inpatient Immunotherapy Outcomes study: A multicenter retrospective study of patients treated with immune checkpoint inhibitors in the inpatient setting.
First Author: Fauzia Riaz
Poster
2022 ASCO Annual Meeting
A deep learning approach utilizing clinical and molecular data for identifying prognostic biomarkers in patients treated with immune checkpoint inhibitors: An ORIEN pan-cancer study.
First Author: Payman Ghasemi Saghand